Memphasys Limited (ASX:MEM)
Australia · Delayed Price · Currency is AUD 0.0050
+0.0005 (11.11%)
At close: Mar 27, 2026
Memphasys Market Cap
Memphasys has a market cap or net worth of 14.24 million as of March 27, 2026. Its market cap has increased by 34.00% in one year.
Market Cap
14.24M
Enterprise Value
18.20M
Revenue
213.98K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since May 14, 2007, Memphasys's market cap has increased from 5.33M to 14.24M, an increase of 167.17%. That is a compound annual growth rate of 5.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 14.24M | -24.32% |
| Dec 31, 2025 | 18.81M | 32.77% |
| Dec 31, 2024 | 14.17M | 4.43% |
| Dec 29, 2023 | 13.57M | 1.01% |
| Dec 30, 2022 | 13.43M | -81.77% |
| Dec 31, 2021 | 73.67M | -2.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HeraMED | 45.77M |
| Micro-X | 41.39M |
| Nova Eye Medical | 37.03M |
| CleanSpace Holdings | 36.69M |
| Atomo Diagnostics | 32.41M |
| ImpediMed | 30.58M |
| CurveBeam AI | 25.32M |
| Control Bionics | 23.89M |